119 related articles for article (PubMed ID: 9772447)
1. [The reversion of multidrug resistance in tumour cell line MCF-7/Adr by ribozyme].
Yuan Y; Zhang J; Zhou D
Zhonghua Yi Xue Za Zhi; 1997 Jul; 77(7):494-6. PubMed ID: 9772447
[TBL] [Abstract][Full Text] [Related]
2. Reversion of multidrug resistance in the P-glycoprotein positive breast cancer cell line (MCF-7/ADR) by introduction of hammerhead ribozyme.
Yuan Y; Zhang J; Scanlon KJ; Lu Z; Qi G
Chin Med Sci J; 1998 Mar; 13(1):24-8. PubMed ID: 11717919
[TBL] [Abstract][Full Text] [Related]
3. [Reversing multidrug resistance in breast cancer cell line MCF-7/ADR by small interfering RNA].
Li CB; Zhang F; Shi YR; Wei XY; Yang Y; Niu RF
Ai Zheng; 2004 Dec; 23(12):1605-10. PubMed ID: 15601546
[TBL] [Abstract][Full Text] [Related]
4. Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of a hammerhead ribozyme.
Holm PS; Scanlon KJ; Dietel M
Br J Cancer; 1994 Aug; 70(2):239-43. PubMed ID: 7914421
[TBL] [Abstract][Full Text] [Related]
5. [Reversion of multidrug resistance in vitro of lung adenocarcinoma by mdr1 ribozyme].
Chen L; Liu Y
Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):189-91. PubMed ID: 11778227
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
[TBL] [Abstract][Full Text] [Related]
7. Overcoming multi-drug resistance by anti-MDR1 ribozyme.
Wang H; Chen XP; Qiu FZ
World J Gastroenterol; 2003 Jul; 9(7):1444-9. PubMed ID: 12854138
[TBL] [Abstract][Full Text] [Related]
8. Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines.
Li WJ; Zhong SL; Wu YJ; Xu WD; Xu JJ; Tang JH; Zhao JH
Mol Biol Rep; 2013 Nov; 40(11):6143-50. PubMed ID: 24078162
[TBL] [Abstract][Full Text] [Related]
9. Modulation of multidrug resistance gene expression in human breast cancer cells by (-)-gossypol-enriched cottonseed oil.
Ye W; Chang HL; Wang LS; Huang YW; Shu S; Dowd MK; Wan PJ; Sugimoto Y; Lin YC
Anticancer Res; 2007; 27(1A):107-16. PubMed ID: 17352222
[TBL] [Abstract][Full Text] [Related]
10. [Reversal of multidrug resistance of tumor cells by anti-mdr1 ribozyme].
Gao P; Zhou GY; Zhang QH; Zhou CJ; Zhen JH; Sun YL
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):251-4. PubMed ID: 15256119
[TBL] [Abstract][Full Text] [Related]
11. [Effects of schisandrin B on reversing multidrug resistance in human breast cancer cells transfected with mdr1 gene].
Li L; Wang T; Xu ZL; Yu Y; Chen W; Chen F
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1633-7. PubMed ID: 16185533
[TBL] [Abstract][Full Text] [Related]
12. Constructing the eukaryotic expression vector to study preliminarily the functions of hammerhead ribozyme targeting base excision repair gene HOGG1.
Zhang ZZ; Zhang Q; Wu M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):165-70. PubMed ID: 16608066
[TBL] [Abstract][Full Text] [Related]
13. The role of c-myc in regulating mdr1 gene expression in tumor cell line KB.
He Y; Zhang J; Zhang J; Yuan Y
Chin Med J (Engl); 2000 Sep; 113(9):848-51. PubMed ID: 11776085
[TBL] [Abstract][Full Text] [Related]
14. [Reversion of multidrug resistance (MDR) in human glioma cells by RNA interference (RNAi)].
Zhao P; Hu W; Zhang YZ; Sun MZ; He Y
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):183-7. PubMed ID: 16875601
[TBL] [Abstract][Full Text] [Related]
15. Reversal of multidrug resistance by a liposome-MDR1 ribozyme complex.
Masuda Y; Kobayashi H; Holland JF; Ohnuma T
Cancer Chemother Pharmacol; 1998; 42(1):9-16. PubMed ID: 9619752
[TBL] [Abstract][Full Text] [Related]
16. Restoration of chemosensitivity in cancer cells with MDR phenotype by deoxyribozyme, compared with ribozyme.
Xing AY; Shi DB; Liu W; Chen X; Sun YL; Wang X; Zhang JP; Gao P
Exp Mol Pathol; 2013 Jun; 94(3):481-5. PubMed ID: 23531420
[TBL] [Abstract][Full Text] [Related]
17. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
18. Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance.
Chen G; Waxman DJ
J Pharmacol Exp Ther; 1995 Sep; 274(3):1271-7. PubMed ID: 7562498
[TBL] [Abstract][Full Text] [Related]
19. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin.
Gao A; Wang X; Xiang W; Liang H; Gao J; Yan Y
J Pharm Pharmacol; 2010 Mar; 62(3):393-9. PubMed ID: 20487225
[TBL] [Abstract][Full Text] [Related]
20. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
Xiang W; Gao A; Liang H; Li C; Gao J; Wang Q; Shuang B; Zhang J; Yan Y; Wang X
Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
